BNET Industries
Market Cap:$2.3B
Last Fiscal Year Sales:$1.7B
- Public
- US
Dow Jones Description
PerkinElmer, Inc. is a global technology leader driving growth and innovation in Health Sciences and Photonics markets to improve the quality of life. Combining operational excellence and technology expertise with an intimate understanding of its customers' needs, PerkinElmer provides products and services for a range of applications that require innovation, precision and reliability. We design, manufacture, market and service products and systems within two business units: Life and Analytical Sciences: A leading provider of precision instrumentation, reagents and chemistries, software and services for a wide range of scientific and industrial laboratory applications, including genetic screening, drug discovery and development, environmental monitoring, food and beverage quality, and chemical analysis. Optoelectronics: Providing a broad range of digital imaging, sensor and specialty lighting components used in biomedical, consumer products and other specialty end markets.
Chief Executive Officer & President
Robert F. FrielNumber of Employees 7,900
Contact Information
940 Winter Street
Waltham, Massachusetts 02451
(781) 663-6900
Peer Companies
NAICS Code Analytical Laboratory Instrument Manufacturing: 334516
Recent Events
-
Reportlinker Adds Biotechnology Instrumentation - International Market Trends
-
PerkinElmer Launches New AlphaScreenR SureFireR and AlphaLISAR "No Wash" Immunoassay and Cellular Pathway Mapping Kits
-
PerkinElmer Introduces Expanded Reagent, Imaging, and Detection System Offerings for Advancing Research and Discovery at...
-
Reportlinker Adds Gas Chromatography Systems - World Review
-
PerkinElmer unveils chromatography collaboration
-
PerkinElmer expands presence in Asia
-
PerkinElmer Announces Financial Results for the Third Quarter of 2009
-
PerkinElmer signs agreement with Corning to develop label-free detection technologies
-
PerkinElmer Launches New EnSpireâ„¢ Multilabel Plate Readers with Luminescence Capability, for Primary and Stem Cell...
-
PerkinElmer Launches New EnSpireTM Multilabel Plate Readers with Luminescence Capability, for...
-
PerkinElmer Launches New EnSpire Multilabel Plate Readers with Luminescence Capability, for Primary and Stem Cell...
-
PerkinElmer Launches New EnSpire„ Multilabel Plate Readers with Luminescence Capability, for Primary and Stem Cell...
-
PerkinElmer Launches Hyphenated Scientific Instrumentation
-
PerkinElmer, Inc. PKI Launches ColumbusTM 2.0 High Content Screening Platform for High-Volume Image Data Management...
-
PerkinElmer Releases Columbus 2.0 High Content Screening Platform
-
PerkinElmer acquires GE Healthcare's radiochemical assets
-
Dividend.com Morning Playbook
-
PerkinElmer skids on 2Q revenue and lower outlook
-
Stocks End Mixed on GDP News
-
Market Winners & Losers: AIG, CIT
News & Analysis
Filter by
finance and perkinelmer inc. - All News and Analysis
PerkinElmer, Inc. Q1 2009 Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions. Your first question will come from the line of Ross Muken with Deutsche Bank. Please proceed. Ross Muken - Deutsche Bank On the diagnostic assets, could you dig a little deeper on sort of some of the trends you have seen in that business, and...
PerkinElmer Inc. Q4 2008 Earnings Call Transcript
Question-and-Answer SessionOperator Operator instructions And your first question comes from the line of Quintin Laid with Robert W. Baird. You may proceed. Quintin Lai - Robert W. Baird & Co., Inc. Hi, good afternoon. As you were looking through the performance in the fourth quarter, was it a steady...
PerkinElmer Inc. Q3 2008 Earnings Conference Call Transcript
Question-and-Answer Session[Operator Instructions]. Michael A. Lawless - Investor Relations Hello, operator, we may be having some technical difficulties. We are not hearing any questions on our end. Operator Please stand by. Your first question comes from the line of Vivek Khanna. Please proceed. Unidentified Analyst Hello, can you hear...
Earnings Preview: PerkinElmer
PerkinElmer PKI is expected to report Q3 earnings with a conference call scheduled for 5:00 pm ET. Guidance Analysts are looking for a profit of 36c on revenue of $503.11M. The consensus range is 34c to 37c for EPS, and revenue of 488M to $516M, according to First Call. For...
PerkinElmer to Highlight Novel Drug Discovery Solutions at IBC World Congress
Business/Technology Editors and Health/Medical Writers BOSTON--BUSINESS WIRE--July 31, 2002 PerkinElmer, Inc. (NYSE:PKI) a leading provider of drug discovery, life science research and genetic disease screening solutions, will spotlight numerous new products and solutions at IBC's 7th Annual World Congress, Drug Discovery TechnologyTM 2002. PerkinElmer will exhibit at Booth...
PerkinElmer Presented Frost & Sullivan Award for Packard Bioscience Acquisition; Prestigious Merger and Acquisition Strategy Award
Business/Technology Editors BOSTON--BUSINESS WIRE--March 18, 2002 PerkinElmer, Inc. (NYSE:PKI), a leading provider of drug discovery, life science research and genetic disease screening solutions, today announced that its PerkinElmer Life Sciences business unit has been selected as the winner of Frost & Sullivan's 2002 Merger & Acquisition Strategy Award...
PerkinElmer to Present At 2002 Merrill Lynch Pharmaceutical, Biotechnology & Medical Device Conference
Business/Technology Editors and Health/Medical Writers BOSTON--BUSINESS WIRE--Feb. 5, 2002 PerkinElmer, Inc. (NYSE:PKI) today announced that it will present at the 2002 Merrill Lynch Pharmaceutical, Biotechnology & Medical Device Conference at 2:10 p.m. ET on Thursday, February 7, 2002, at the Grand Hyatt Hotel in New York City. ...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Robert F. Friel | Chief Executive Officer & President |
| Daniel R. Marshak | Vice President & Chief Scientific Officer |
| John P Murphy | Chief Operating Officer |
| Michael L. Battles | Vice President & Chief Accounting |
| Richard Walsh | Senior Vice President & Chief Administrative Officer |
| John A. Roush | Senior Vice President and President, Optoelectronics |
| Katherine A. O'Hara | General Counsel & Senior Vice President |
| Robert Barrett | Senior Vice President & President, Fluid Sciences |
| Aaron Geist | Vice President, Business Development |
| Rick Weiler | Vice President, Sales, Marketing Communications |
| Francine Bernitz | Director, Marketing |
| Jean-Rene Pinaud | Marketing Director |
| Karl Hecker | Director, Research & Development |
| Paul Gardiner | Marketing Director |
| Ph Chan | Regional Marketing Director |
| Bob Falkenberg | Product Marketing Manager |
| Brian McNealey | Product Manager |
| Iain McConnell | Product Marketing Manager |
| Kevin Kolmetz | Marketing Manager |
| Mark Acton | Product Manager, Marketing |
| Michael Ross | Seals Marketing Manager |
| Robert Menendez | Product Manager |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Gregory L. Summe | Executive Chairman |
| Alexis P. Michas | Board of Directors |
| G. Robert Tod | Board of Directors |
| Gabriel Schmergel | Board of Directors |
| James C. Mullen | Board of Directors |
| Kenton J. Sicchitano | Board of Directors |
| Nicholas A. Lopardo | Board of Directors |
| Patrick J. Sullivan | Board of Directors |
| Vicki L. Sato | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Chief Executive Officer & President | Current |
| Bioveda | Executive Vice President and Chief Financial Officer | Current |
| Millennium Pharmaceuticals, Inc. | Chairman | Current |
| PerkinElmer, Inc. | Board of Directors | Current |
| Fairchild Semiconductor International, Inc. | Vice Chairman & President, Life & Analytical Sciences, Perkinelmer, Inc. | Former |
| PerkinElmer, Inc. | Executive Vice President | Former |
| AlliedSignal, Inc. | Former |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Vice President & Chief Scientific Officer | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Chief Operating Officer | Current |
| Bioveda | Executive Vice President and Chief Operating Officer | Current |
| PerkinElmer, Inc. | Executive Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Vice President & Chief Accounting | Current |
| PerkinElmer, Inc. | Corporate Controller | Former |
| PerkinElmer, Inc. | Board of Directors | Former |
| University of Vermont | Bachelor of Science Degree In Business Administration | Former |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Senior Vice President & Chief Administrative Officer | Current |
| PerkinElmer, Inc. | Senior Vice President of Human Resources | Former |
| Villanova University | Master of Arts Degree In Counseling | Former |
| La Salle University | Master of Business Administration | Former |
| La Salle University | Bachelor of Science In Business Administration | Former |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer Optoelectronics | President | Current |
| PerkinElmer, Inc. | Senior Vice President and President, Optoelectronics | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | General Counsel & Senior Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Senior Vice President & President, Fluid Sciences | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Vice President, Business Development | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Vice President, Sales, Marketing Communications | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Director, Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Marketing Director | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Director, Research & Development | Current |
| PerkinElmer, Inc. | Director, Research & Development | Former |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Marketing Director | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Regional Marketing Director | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Product Marketing Manager | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Product Manager | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Product Marketing Manager | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Marketing Manager | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Product Manager, Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Seals Marketing Manager | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Product Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Goldman Sachs Capital Partners | Senior Advisor | Current |
| PerkinElmer, Inc. | Executive Chairman | Current |
| State Street Corporation | Board of Directors | Current |
| PerkinElmer, Inc. | President & CEO | Former |
Mr. Michas is a co-founder of Stonington Partners and has served as its Managing Partner since inception. He has been engaged in private equity investing since 1984, having served as an investment professional with Merrill Lynch Capital Partners from 1984 to 1994. Previously, he had been an investment banker with Merrill Lynch & Co. He is currently a director of the following Stonington portfolio companies: Goss International Corporation, HK Systems, Inc., Global Motorsport Group, Inc., and Lincoln Educational Services Corporation. Mr. Michas received his M.B.A. from Harvard Business School and his B.A. from Harvard College.
| Organization | Position | Status |
|---|---|---|
| Stonington Partners Inc. | Chief Operating Officer | Current |
| Airline Bulletin | Director | Current |
| PerkinElmer, Inc. | Board of Directors | Current |
| Air-Tran Company, Inc. | Board of Directors | Current |
| AirTran Airways Corp. | Board of Directors | Current |
| AirTran Holdings, Inc. | Director | Current |
| Lincoln Educational Services Corporation | Board of Directors | Current |
| Stonington Partners Inc. | Board Director | Current |
| Florida Culinary Institute | Board of Directors | Current |
| Dailyfinance | Director | Current |
| Stonington Partners Inc. | Managing Partner | Former |
| Florida Culinary Institute | Committee Member | Current |
| Stonington Partners Inc. | Co-Founder | Former |
| Stonington Partners Inc. | Managing Ptnr | Former |
| Harvard University | M.B.A. | Former |
| Harvard University | A.B. | Former |
| Harvard College | Bachelor of Arts Degree | Former |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Board of Directors | Current |
James C. Mullen is President and Chief Executive Officer of Biogen Idec and has served in these positions since the merger in November 2003. Mr. Mullen joined Biogen Inc. in 1989. He was named Chief Executive Officer in 2000 and Chairman in 2002. Prior to being named CEO and Chairman, he also held the positions of President and Chief Operating Officer (1999-2000); Vice President, International (1996-1999); Vice President, Operations (1992-1996); and Director, Facilities and Engineering (1989-1992). Mr. Mullen is a member of the Board of Directors of PerkinElmer Inc. and the Biomedical Science Careers Program Inc. He holds a B.S. in Chemical Engineering from Rensselaer Polytechnic Institute and an M.B.A. from Villanova University.
| Organization | Position | Status |
|---|---|---|
| Biogen Idec, Inc. | CEO & President | Current |
| Biogen Idec, Inc. | Board of Directors | Current |
| PerkinElmer, Inc. | Board of Directors | Current |
| Biotechnology Industry Organization | Chairman | Former |
| PerkinElmer, Inc. | Director | Former |
| Villanova University | M.B.A. | Former |
| Villanova University | B.S. In Chemical Engineering | Former |
Mr. Sicchitano, age 64, has been retired since June 2001. He joined Price Waterhouse LLP, a predecessor firm of PricewaterhouseCoopers LLP, in 1970 and became a partner in 1979. PricewaterhouseCoopers LLP, or PwC, is a public accounting firm. At the time of his retirement, Mr. Sicchitano was the Global Managing Partner of Independence and Regulatory Matters for PwC. During his 31-year tenure with PwC, Mr. Sicchitano held various positions including the Global Managing Partner of Audit/Business Advisory Services and the Global Managing Partner responsible for Audit/Business Advisory, Tax/Legal and Financial Advisory Services. Mr. Sicchitano also serves as a director of PerkinElmer, Inc. and MetLife, Inc. Mr. Sicchitano is a certified public accountant.
| Organization | Position | Status |
|---|---|---|
| Analog Devices, Inc. | Chairman | Current |
| PerkinElmer, Inc. | Board of Directors | Current |
| MetLife, Inc. | Board of Directors | Current |
| Analog Devices, Inc. | Board of Directors | Current |
| PricewaterhouseCoopers | Global Managing Partner of Independence and Regulatory Matters | Former |
| New England Aquarium | Trustee | Former |
| Harvard Business School Alumni Association | Board of Directors | Former |
| New England Deaconess Hospital | Board of Directors | Former |
| Harvard Business School | MBA | Former |
| Harvard College | Bachelor’s Degree | Former |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Hologic, Inc. | Chairman | Current |
| PerkinElmer, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| PerkinElmer, Inc. | Board of Directors | Current |
Executive News
-
Biogen makes bid for Facet: Purchase of Calif. biotech company estimated at $355M
-
Biogen offers to buy Facet
-
Biogen Idec makes hostile bid for Redwood City's Facet
-
Biogen Idec, Inc. (Massachusetts) (BIIB) (JOBS) Offers To Buy Facet Biotech For $356M
-
Biogen Idec verkündet Angebot, alle ausgegebenen Aktien von Facet für 14,50 USD pro Stück in bar zu erwerben
-
3rd UPDATE: Biogen Idec Offers $356 Million For Facet Biotech
-
Biogen tries to prolong onco deal trend
-
Biogen Idec Makes Hostile Bid To Acquire Facet Biotech
-
Biogen Idec Makes Hostile Bid To Acquire Facet Biotech For $14.50/shr In Cash - Update
-
Biogen Idec, Inc. (Massachusetts) (BIIB) Announces Proposal to Acquire All Outstanding Shares of Facet Biotech for $14.50 per Share in Cash 9/4/2009
-
Biogen Idec makes hostile bid for Redwood City's Facet
-
Biogen Makes Hostile Bid for Facet Biotech
-
Market Report -- In Play (FACT)
-
Biogen Idec makes bid for Facet Biotech
-
PerkinElmer Second Quarter Earnings and Conference Call Notification
-
CareFusion names new board member
-
CareFusion Names Robert Friel to Board of Directors
-
CareFusion Names Robert Friel to Board of Directors
-
CareFusion Names Robert Friel to Board of Directors
-
CareFusion Names Robert Friel to Board of Directors
Industry Transcripts by Seeking Alpha
-
Synergetics USA, Inc. F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about SURG
-
Cantel Medical Corp. F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 09, 2009about CMN
-
The Cooper Companies, Inc. F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 08, 2009about COO
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL

